Validation of Medicaid claim-based opioid treatment program retention quality measures.

ABSTRACT:

Introduction

Understanding the quality of care that opioid treatment programs (OTPs) deliver is a long-standing goal in the United States. In a prior study, this study team developed casemix adjusted OTP-level quality measures of patient retention that revealed a median 180-day OTP retention rate of 26% (25th percentile = 11%; 75th percentile = 37%) in Measurement Year (MY) 2023 (July 1, 2022 - June 30, 2023). The present study evaluated the measures' validity, particularly the association between each OTP's retention and their rate of substance use disorder (SUD) hospitalizations or emergency department (ED) visits, SUD-related mortality, and all-cause mortality.

Methods

This study used previously developed OTP retention measures derived from Medicaid claims data to ascerta

SUBMITTER: Burke KN 

PROVIDER: S-EPMC13648295 | biostudies-literature | 2026 Dec

REPOSITORIES: biostudies-literature